M. Jean Gilbert

University of Nebraska at Omaha — United States

Immunology and Microbiology · Life Sciences

24h-index4.3kcitations59works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(11), Cytomegalovirus and herpesvirus research(10), Substance Abuse Treatment and Outcomes(8), Herpesvirus Infections and Treatments(7), Immune Cell Function and Interaction(7)

Publications59 total

American Indian and Alaska Native Understandings of Cancer Through Poetry: A Holistic Experience
Genealogy·2025Open Access
Communicating Native American Cancer Efforts and Resources in the Great Plains
Great Plains research·2023Open Access
Urban American Indian Community Health Beliefs Associated with Addressing Cancer in the Northern Plains Region
Journal of Cancer Education·2020· 13 citedOpen Access
Judy.
PubMed·2019Open Access
Policymaking Roles for Applied Anthropologists: Personally Ensuring That Your Research Is Used
2019
IMST-13. DEXAMETHASONE ENHANCES CTLA-4 EXPRESSION DURING T CELL ACTIVATION
Neuro-Oncology·2016Open Access
A phase I dose-escalation study of TKM-080301, a RNAi therapeutic directed against polo-like kinase 1 (PLK1), in patients with advanced solid tumors: Expansion cohort evaluation of biopsy samples for evidence of pharmacodynamic effects of PLK1 inhibition.
Journal of Clinical Oncology·2013· 19 cited
Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.
Cancer Research·2013· 31 cited
Humboldt Community Action Plan
PDXScholar (Portland State University)·2009Open Access
Cultural Relevance in the Delivery of Human Services
2008
Connections & Edges: 2040 Lincoln District Vision Plan
PDXScholar (Portland State University)·2008Open Access
Protecting the faces of health care workers: knowledge gaps and research priorities for effective protection against occupationally-acquired respiratory infectious diseases
Open Collections·2008· 32 citedOpen Access
Toxicity from the recreational use of 1-benzylpiperazine
Clinical Toxicology·2008· 66 cited
Sargramostim (Leukine®/GM-CSF) for Autologous (Au) or Allogeneic (Allo) Bone Marrow Transplant (BMT) Engraftment Delay or Failure (ED/F) After Total Body Irradiation Conditioning (TBI)
International Journal of Radiation Oncology*Biology*Physics·2007Open Access
Genetic Modification of T Cell Clones to Improve the Safety and Efficacy of Adoptive T Cell Therapy
Novartis Foundation symposium·2007· 2 cited
Phase II study of the combination of thalidomide and irinotecan in patients with recurrent anaplastic gliomas not on enzyme inducing anticonvulsants
Journal of Clinical Oncology·2006· 2 cited
Building Relationships with General Contractors: Transforming Standard Practice
2006· 1 cited
Trends in Injuries, Illnesses, and Policies in Canadian Healthcare Workplaces
Canadian Journal of Public Health·2005· 52 citedOpen Access
Phase II trial of thalidomide in combination with irinotecan in adults with recurrent glioblastoma multiforme
Journal of Clinical Oncology·2005· 3 cited
Final results from PROGRESS trial of sargramostim (GM-CSF) in combination with irinotecan (I), 5-fluorouracil (F), and leucovorin (L) for metastatic colorectal cancer (CRC)
Journal of Clinical Oncology·2005
page 1 of 3Next →

Frequent Co-authors

Philip D. Greenberg(10), Stanley R. Riddell(9), Jan M. Agosti(4), John Mills(4), Stephen D. Lupton(3), Robert W. Overell(3), Richard C. Cervantes(3), James B. Whitmore(3), Luís Fernando de Macedo Brígido(3), Käthe S. Watanabe(2), Lawrence Corey(2), S. Riddell(2), Annalee Yassi(2), Ramesh K. Ramanathan(2), Solomon I. Hamburg(2), Mitesh J. Borad(2), ­Mahesh Seetharam(2), Peter P. Lee(2), Paul Fredlund(2), Sean C. Semple(2)